SOL Capital Management CO Sells 842 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

SOL Capital Management CO cut its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 2.7% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 30,042 shares of the exchange traded fund’s stock after selling 842 shares during the period. SOL Capital Management CO’s holdings in SPDR S&P Biotech ETF were worth $2,436,000 at the end of the most recent reporting period.

Other large investors have also recently made changes to their positions in the company. Provident Wealth Management LLC increased its holdings in shares of SPDR S&P Biotech ETF by 3,000.0% in the 1st quarter. Provident Wealth Management LLC now owns 310 shares of the exchange traded fund’s stock worth $25,000 after buying an additional 300 shares during the last quarter. Kohmann Bosshard Financial Services LLC bought a new stake in shares of SPDR S&P Biotech ETF in the 4th quarter worth about $29,000. Lee Danner & Bass Inc. bought a new stake in shares of SPDR S&P Biotech ETF in the 4th quarter worth about $38,000. Addison Advisors LLC increased its holdings in shares of SPDR S&P Biotech ETF by 27.4% in the 4th quarter. Addison Advisors LLC now owns 535 shares of the exchange traded fund’s stock worth $48,000 after buying an additional 115 shares during the last quarter. Finally, Golden State Wealth Management LLC increased its holdings in shares of SPDR S&P Biotech ETF by 100.0% in the 1st quarter. Golden State Wealth Management LLC now owns 638 shares of the exchange traded fund’s stock worth $52,000 after buying an additional 319 shares during the last quarter.

SPDR S&P Biotech ETF Stock Down 0.7%

SPDR S&P Biotech ETF stock opened at $83.27 on Thursday. SPDR S&P Biotech ETF has a twelve month low of $66.66 and a twelve month high of $105.47. The company’s 50-day moving average price is $80.64 and its 200-day moving average price is $85.41. The company has a market cap of $4.48 billion, a PE ratio of 11.47 and a beta of 0.85.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.